Haematopoiesis is a life-long, highly regulated, multi-stage process where self-renewing haematopoietic stem cells (HSCs) give raise to all blood cell lineages. This process is controlled, at least in part, through the combinatorial action of lineagerestricted, and also more widely expressed, transcription factors [1, 2] . There is also strong evidence that microRNAs (miRNAs) are involved in both normal haematopoiesis and haematological malignancies [3, 4] .
and nuclear factor I/A (NFI-A). C-EBP␣ and NFI-A control granulocytic differentiation in acute promyelocytic leukaemia cell lines treated with all-trans retinoic acid
. These observations indicate that miR-223 is an important regulator of haematopoiesis and is also involved in malignant transformation. Although the primary influence of miR-223 was reported to be on granulopoiesis, a recent study in mice showed miR-223 to negatively regulate progenitor proliferation and granulocyte differentiation. The target of miR-223 was determined to be a transcription factor, Mef2c, that promotes myeloid progenitor proliferation [12] .
In 
Materials and methods

Cell lines and cell culture
The following human leukaemia cell lines were used in this study: K562 [13] [14] . The ploidy classes were determined following flow cytometric analysis after propidium iodide (PI) staining. 
(human erythroleukaemia cell line), HEL (human erythroleukaemia cell line), HL-60 (human promyelocytic leukaemia cell line), Jurkat (human acute T-cell leukaemia cell line), HUT-78 (human T-lymphoma cell line), CMK (human megakaryoblastic leukaemia cell line), 3D5 (human B cell line), Raji (human B-non-Hodgkin's lymphoma cell line) and THP-1 (human monocytic leukaemia cell line). All cells were grown in RPMI 1640 media (Gibico BRL, Grand Island, NY, USA) supplemented with 10% FBS (Gibico BRL) at 37°C in 5% CO2.
Erythroid and megakaryocytic induction of K562 cells
Erythroid differentiation of K562 cells was induced with 40 M haemin (Sigma-Aldrich, Deisenhofen, Germany), whereas megakaryocytic differentiation was induced with 5 ng/ml phorbol myristate acetate (PMA) (SigmaAldrich). Erythroid differentiation of K562 cells was assessed by the benzidine cytochemical test
Isolation of normal haematopoietic lineage cells
CACTTTGTCAAGCTCA-3Ј), GAPDH RW (5Ј-GCTGGTGGTCCAGGGGTCT-TACT-3Ј). Comparative real-time PCR was performed in triplicate and the expression level of each mRNA was normalized to GAPDH mRNA. Relative expression was calculated by using the CT method.
Real-time quantification of miRNAs by stem-loop RT-PCR
Real-time PCR for miR-223 was executed as described previously [15] .
Specifically, reverse transcription reaction contained a combination of RT primers including oligo dT and miR-223 stem-loop primer (5Ј-GTCG-TATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGGGGTA-3Ј) with total RNA from K562 cells or each of the four stable transfectant pools. Reversed miR-223 was amplified with the following primers: miR-223 FW (5Ј-TGTCGTGTCAGTTTGTCAAATAC-3Ј) and miR-223 RW (5Ј-GTGCAGGGTCC-GAGGTATTC-3Ј). GAPDH mRNA was used as an internal control in the system
and miR-223 expression was relatively quantified using CT method [16] . (Fig. 1B) . (Fig. 4A) . [18] . The putative miR-223 binding sites are conserved in several species (Fig. 7C) . (Fig. 7A) .
Western blotting
Total cell extracts were fractionated by electrophoresis on 12% SDS polyacrylamide gels. Proteins were transfered to polyvinylidene difluoride membranes (Amersham, Buckinghamshire, UK), and the membranes were incubated with anti-LMO2 antibody (Abnova, Taipei, Taiwan). Immunoreactivity was determined using the ECL method (Amersham).
Results
MiR-223 expression in human haematopoietic tissues and cells
MiR-223 expression was also detected in established human leukaemia cell lines (Fig. 1C). MiR-223 was highly expressed not only in HL-60 and THP-1 cell lines of myeloid origin but also in K562 and HEL cell lines of erythroid origin. There was no detectable signal in the two cell lines of B cell origin (3D5 and Raji), the two cell lines of T cell origin (Jurkat and Hut-78), or the one cell line of megakaryocytic origin (CMK). The miR-223 expression in erythroid cells, K562 and HEL cells deserved our interests.
Effect of haemin and PMA on miR-223 expression in K562 cells
MiR-223 overexpression was also demonstrated with the miR-223 reporters rev-miR-223-pEGFP-C1 and rev-miR223-pRL-TK. Both fluorescence expression and relative luciferase activity exhibited significant decreases in pcDNA3.1-pri-miR-223/K562-1 (K-223-1) cells transiently transfected with rev-miR-223-pEGFP-C1 and rev-miR-223-pRL-TK, respectively. These results confirmed the overexpression of miR-223 in the stable transfectants pcDNA3.1-pri-miR-223/K562 (Fig. 4B and C). To assess the influence of enforced expression of miR-223 on erythroid differentiation, the number of benzidine-positive cells was determined after 0, 24, 48, 72 and 96 hrs of haemin treatment of pcDNA3.1/K562 and pcDNA3.1-pri-miR-223/K562 cells. A gradual and significant increase in the percentage of benzidinepositive cells was observed in pcDNA3.1/K562 cells with haemin treatment. In contrast, only slight, insignificant increases in the four pcDNA3.1-pri-miR-223/K562 were observed (Fig. 5A). Less than 15% of cells were benzidine-positive after 96 hrs of haemin treatment. Erythroid differentiation potentiality of the pcDNA3.1-pri-miR-223/K562 cells was also examined by real-time PCR analysis of ␥-globin mRNA. The ␥-globin mRNA levels were much lower in pcDNA3.1-pri-miR-223/K562 compared with those in pcDNA3.1/K562 both before and after haemin induction for 48 hrs (Fig. 5B). Similar results were also observed in pSilencer-2.1-U6-Neo-pre-miR-223/K562 (data not shown). These results demonstrated that the enforced expression of miR-223 resulted in suppression of erythroid differentiation of K562 cells.
Fig. 4 Overexpression of miR-223 in stable transfectants. (A) miR-223 expression in stable transfectants analysed by miRNA real-time PCR. Comparative miRNA real-time PCR was performed in triplicate and expression level was normalized to GAPDH mRNA. K represents the stable transfectant pcDNA3.1/K562 (a combination of two stable transfectant pools pcDNA3.1/K562-1 and -2). K-223-1, 2, 3, 4 represent stable transfectant pools pcDNA3.1-pri-miR-223/K562-1, 2, 3, 4, respectively. Error bars represent one standard deviation and were obtained from three independent experiments. (B) Fluorescence expression of the miR-223 reporter (rev-miR-223-pEGFP-C1) in pcDNA3.1/K562 cells (K) and pcDNA3.1-pri-miR-223/K562-1 (K223-1) cells transfected transiently with rev-miR-223-pEGFP-C1. The images presented here are phase contrast images and fluorescence images of the same fields (magnification 100ϫ). (C) The relative luciferase activity of the miR-223 reporter (rev-miR-223-pRL-TK) in pcDNA3.1/K562 cells (K) and pcDNA3.1-pri-miR-223/K562-1 (K223-1) cells transfected transiently with rev-miR-223-pRL-TK. Comparative renilla luciferase (pRL-TK) activity assay was performed in triplicate and normalized to firefly (pGL-3). Error bars represent one standard deviation. *, P Ͻ 0.01.
The enforced expression of miR-223 promoted megakaryocytic differentiation of K562 cells
To demonstrate a direct interaction between the 3Ј-UTR of LMO2 mRNA with miR-223, we inserted the 3Ј-UTR region predicted to interact with this miRNA into a luciferase vector pRL-TK. A 50% reduction in relative luciferase activity was observed when NIH-3T3 cells were co-transfected with the miR-223 precursor (pre-miR-223) and the reporter plasmid containing the 3Ј-UTR sequence of LMO2 mRNA (LMO2-pRL-TK). However, the luciferase activity was recovered when the miR-223 inhibitor (anti-miR-223) was co-transfected into NIH-3T3 cells with the miR-223 precursor and LMO2-pRL-TK
Additionally, we used a fluorescence vector (pEGFP-C1) to generate another reporter plasmid containing the 3Ј-UTR sequence of LMO2 (LMO2-pEGFP-C1). As expected, the expression of EGFP is decreased in NIH-3T3 cells cotransfected with pre-miR-223 and LMO2-pEGFP-C1. EGFP expression is the same as control levels when co-transfected with anti-miR-223 in addition to pre-miR-223 and LMO2-pEGFP-C1 (data not shown).
We also tested whether the interaction between miR-223 and LMO2 mRNA was direct by mutating the miR-223 binding site. As expected, miR-223 had no effects on LMO2 mut-pRL-TK that carried the mutant miR-223 binding sites (Fig. 7B and C) . 
reporter (LMO2-pRL-TK) in NIH-3T3 cells treated with premiR-223 (miR-223 precursor) and anti-miR-223 (miR-223 inhibitor). Comparative renilla luciferase (pRL-TK) activity assay was performed in triplicated and normalized to firefly luciferase (pGL-3
